APOB and metabolic syndrome: Expression of IGF-II combined with LDLr−/− ApoB100/100 genotype induces features of metabolic syndrome including insulin resistance, hyperglycemia, and obesity, and promotes AV remodeling within 6 months under a diabetogenic diet.